162 related articles for article (PubMed ID: 4206490)
1. Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.
AvRuskin TW; Sau K; Tang S; Juan C
J Clin Endocrinol Metab; 1973 Sep; 37(3):380-8. PubMed ID: 4206490
[No Abstract] [Full Text] [Related]
2. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
Samaan NA; Leavens ME; Jesse RH
J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
[No Abstract] [Full Text] [Related]
3. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
[No Abstract] [Full Text] [Related]
4. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
5. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
Yen SS; Siler TM; DeVane GW
N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
[No Abstract] [Full Text] [Related]
6. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone.
Smallridge RC; Wartofsky L; Dimond RC
J Clin Endocrinol Metab; 1979 Apr; 48(4):700-5. PubMed ID: 107182
[No Abstract] [Full Text] [Related]
7. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Felt V; Nedvídková J
Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
[No Abstract] [Full Text] [Related]
8. Effect of bromocriptine on serum hormones in acromegaly.
Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
[TBL] [Abstract][Full Text] [Related]
9. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
[No Abstract] [Full Text] [Related]
10. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
Cryer PE; Jacobs LS; Daughaday WH
Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
[No Abstract] [Full Text] [Related]
11. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
Marek J; Límanová Z; Srámková J
Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
[TBL] [Abstract][Full Text] [Related]
12. Acromegaly treated with chlorpromazine. A case study.
Kolodny HD; Sherman L; Singh A; Kim S; Benjamin F
N Engl J Med; 1971 Apr; 284(15):819-22. PubMed ID: 5549804
[No Abstract] [Full Text] [Related]
13. [Hormonal evaluation of 27 patients with acromegaly].
Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
[No Abstract] [Full Text] [Related]
14. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
[No Abstract] [Full Text] [Related]
15. Endocrine effects of naloxone-induced opiate receptor blockade.
Morley JE; Baranetsky NG; Wingert TD; Carlson HE; Hershman JM; Melmed S; Levin SR; Jamison KR; Weitzman R; Chang RJ; Varner AA
J Clin Endocrinol Metab; 1980 Feb; 50(2):251-7. PubMed ID: 6243662
[No Abstract] [Full Text] [Related]
16. [The effects of somatostatin in acromegaly].
Schaison G; Roger M; Milhaud G
Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
[TBL] [Abstract][Full Text] [Related]
17. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Hoyte KM; Martin JB
J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
[No Abstract] [Full Text] [Related]
19. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
[TBL] [Abstract][Full Text] [Related]
20. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
